• European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera ...
查看详情Recently, the Antibody-Drug Conjugates (ADCs) program’s‘Recombinant Humanized anti-HER2 Monoclonal Antibody-Maytansine ...
On September 5 2016,Bio-thera reached a strategic cooperation agreement with world class CRO, Quintiles. Under agreement...
Great news! On May 18, Bio-Thera's recombinant humanized anti-VEGF monoclonal antibody injection(BAT1706) was approved f...
